Lipid-containing osmoprotective eye drops in contact lens wearers

Seray Aslan Bayhan, Hasan Ali Bayhan Ophthalmology Department, Bozok University Faculty of Medicine, Yozgat, TurkeyWe would like to congratulate Kaercher et al1 on their prospective study of Optive Plus (Allergan, Inc., Irvine, CA, USA) in the treatment of patients with dry eye. In this study the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Aslan Bayhan S, Bayhan HA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/a798c97937a4438f991cd5b4ef2dabb3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a798c97937a4438f991cd5b4ef2dabb3
record_format	dspace
spelling	oai:doaj.org-article:a798c97937a4438f991cd5b4ef2dabb32021-12-02T06:21:04ZLipid-containing osmoprotective eye drops in contact lens wearers1177-5483https://doaj.org/article/a798c97937a4438f991cd5b4ef2dabb32014-10-01T00:00:00Zhttp://www.dovepress.com/lipid-containing-osmoprotective-eye-drops-in-contact-lens-wearers-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483 Seray Aslan Bayhan, Hasan Ali Bayhan Ophthalmology Department, Bozok University Faculty of Medicine, Yozgat, TurkeyWe would like to congratulate Kaercher et al1 on their prospective study of Optive Plus (Allergan, Inc., Irvine, CA, USA) in the treatment of patients with dry eye. In this study the authors reported that Optive Plus effectively reduced the signs and symptoms of patients with all types of dry eye and they recommended the use of this artificial tear especially in lipid-deficient dry eye. We think that some important issues need more thorough discussion.View original paper by Kaercher and colleagues.Aslan Bayhan SBayhan HADove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2014, Iss default, Pp 2091-2093 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Aslan Bayhan S Bayhan HA Lipid-containing osmoprotective eye drops in contact lens wearers
description	Seray Aslan Bayhan, Hasan Ali Bayhan Ophthalmology Department, Bozok University Faculty of Medicine, Yozgat, TurkeyWe would like to congratulate Kaercher et al1 on their prospective study of Optive Plus (Allergan, Inc., Irvine, CA, USA) in the treatment of patients with dry eye. In this study the authors reported that Optive Plus effectively reduced the signs and symptoms of patients with all types of dry eye and they recommended the use of this artificial tear especially in lipid-deficient dry eye. We think that some important issues need more thorough discussion.View original paper by Kaercher and colleagues.
format	article
author	Aslan Bayhan S Bayhan HA
author_facet	Aslan Bayhan S Bayhan HA
author_sort	Aslan Bayhan S
title	Lipid-containing osmoprotective eye drops in contact lens wearers
title_short	Lipid-containing osmoprotective eye drops in contact lens wearers
title_full	Lipid-containing osmoprotective eye drops in contact lens wearers
title_fullStr	Lipid-containing osmoprotective eye drops in contact lens wearers
title_full_unstemmed	Lipid-containing osmoprotective eye drops in contact lens wearers
title_sort	lipid-containing osmoprotective eye drops in contact lens wearers
publisher	Dove Medical Press
publishDate	2014
url	https://doaj.org/article/a798c97937a4438f991cd5b4ef2dabb3
work_keys_str_mv	AT aslanbayhans lipidcontainingosmoprotectiveeyedropsincontactlenswearers AT bayhanha lipidcontainingosmoprotectiveeyedropsincontactlenswearers
_version_	1718399954882396160

Lipid-containing osmoprotective eye drops in contact lens wearers

Ejemplares similares